Literature DB >> 24608892

Significant decrease of ethinylestradiol with nevirapine, and of etonogestrel with efavirenz in HIV-positive women.

Nadia K Landolt1, Nittaya Phanuphak, Sasiwimol Ubolyam, Suteeraporn Pinyakorn, Stephen Kerr, Jennisa Ahluwalia, Parawee Thongpaeng, Narukjaporn Thammajaruk, Serge Cremers, Tiffany Thomas, Surasith Chaithongwongwatthana, Joep M A Lange, Jintanat Ananworanich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24608892     DOI： 10.1097/QAI.0000000000000134

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  14 in total

1.  Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy.

Authors:  Catherine A Chappell; Mohammed Lamorde; Shadia Nakalema; Beatrice A Chen; Hope Mackline; Sharon A Riddler; Susan E Cohn; Kristin M Darin; Sharon L Achilles; Kimberly K Scarsi
Journal:  AIDS       Date:  2017-09-10       Impact factor: 4.177

2.  Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception.

Authors:  Jennifer E Balkus; Thesla Palanee-Phillips; Krishnaveni Reddy; Samantha Siva; Ishana Harkoo; Clemensia Nakabiito; Kenneth Kintu; Gonasangrie Nair; Catherine Chappell; Flavia Matovu Kiweewa; Samuel Kabwigu; Logashvari Naidoo; Nitesha Jeenarain; Mark Marzinke; Lydia Soto-Torres; Elizabeth R Brown; Jared M Baeten
Journal:  J Acquir Immune Defic Syndr       Date:  2017-10-01       Impact factor: 3.731

3.  Interactions between etonogestrel-releasing contraceptive implant and 3 antiretroviral regimens.

Authors:  Regis Kreitchmann; Alice Stek; Brookie M Best; Edmund Capparelli; JiaJia Wang; David Shapiro; Nahida Chakhtoura; Mark Mirochnick; Ahizechukwu C Eke
Journal:  Contraception       Date:  2021-08-15       Impact factor: 3.375

Review 4.  Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV.

Authors:  Kimberly K Scarsi; Kristin M Darin; Catherine A Chappell; Stephanie M Nitz; Mohammed Lamorde
Journal:  Drug Saf       Date:  2016-11       Impact factor: 5.606

Review 5.  Current and future contraceptive options for women living with HIV.

Authors:  Rena C Patel; Elizabeth A Bukusi; Jared M Baeten
Journal:  Expert Opin Pharmacother       Date:  2017-09-19       Impact factor: 3.889

6.  Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy.

Authors:  Maria Pyra; Renee Heffron; Nelly R Mugo; Kavita Nanda; Katherine K Thomas; Connie Celum; Athena P Kourtis; Edwin Were; Helen Rees; Elizabeth Bukusi; Jared M Baeten
Journal:  AIDS       Date:  2015-11       Impact factor: 4.177

Review 7.  Multipurpose prevention technologies: the future of HIV and STI protection.

Authors:  José A Fernández-Romero; Carolyn Deal; Betsy C Herold; John Schiller; Dorothy Patton; Thomas Zydowsky; Joe Romano; Christopher D Petro; Manjulaa Narasimhan
Journal:  Trends Microbiol       Date:  2015-03-07       Impact factor: 17.079

8.  Reduced Effectiveness of Contraceptive Implants for Women Taking the Antiretroviral Efavirenz (EFV): Still Good Enough and for How Long?

Authors:  James D Shelton
Journal:  Glob Health Sci Pract       Date:  2015-12-08

Review 9.  Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices.

Authors:  Asa Radix; Jae Sevelius; Madeline B Deutsch
Journal:  J Int AIDS Soc       Date:  2016-07-17       Impact factor: 5.396

10.  Contraceptive challenges in adolescents living with or at risk of HIV.

Authors:  Nadia Kancheva Landolt; Torsak Bunupuradah; Surasith Chaithongwongwatthana
Journal:  J Virus Erad       Date:  2016-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.